Azo Nanotechnology -- Annually, 50 to 100 million people worldwide receive surgical implants. Some 1 to 7% of the patients suffer serious complications due to bacterial infection; therefore, prevention of such implant-associated infections is a high priority. Scientists from the KIT Institute for Biological Interfaces (IBG) have now succeeded in identifying highly active mini protein chains that are good candidates as an anti-bacterial coating of implants (Chemistry + Science, vol. 16, issue 1).
